HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mathew Garnett Selected Research
Mathew Garnett Research Topics
Disease
9
Neoplasms (Cancer)
01/2022 - 11/2005
1
Breast Neoplasms (Breast Cancer)
01/2020
1
Colorectal Neoplasms (Colorectal Cancer)
01/2020
1
Necrosis
01/2018
1
Malignant Mesothelioma
01/2018
1
Carcinogenesis
02/2017
1
Melanoma (Melanoma, Malignant)
01/2015
1
Colonic Neoplasms (Colon Cancer)
11/2012
1
Lung Neoplasms (Lung Cancer)
11/2012
Drug/Important Bio-Agent (IBA)
3
Phosphotransferases (Kinase)
IBA
02/2013 - 11/2005
2
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2018
2
ErbB Receptors (EGF Receptor)
IBA
02/2013 - 11/2012
1
Caspase 8 (Caspase-8)
IBA
01/2022
1
CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)
IBA
01/2022
1
Drug Combinations
IBA
01/2020
1
BMS 754807
IBA
01/2020
1
Proteins (Proteins, Gene)
FDA Link
01/2020
1
Insulin Receptor
IBA
01/2020
1
dabrafenib
IBA
01/2020
1
Deubiquitinating Enzymes
IBA
01/2018
1
Ligands
IBA
01/2018
1
Death Domain Receptors
IBA
01/2018
1
Odorant Receptors (Odorant Receptor)
IBA
02/2017
1
trametinib
IBA
01/2015
1
VS-5584
IBA
02/2013
1
Mechanistic Target of Rapamycin Complex 1
IBA
02/2013
1
Mediator Complex
IBA
11/2012
1
Tyrosine (L-Tyrosine)
FDA Link
11/2012
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
11/2012
1
Gefitinib (Iressa)
FDA Link
11/2012
1
Protein Isoforms (Isoforms)
IBA
11/2005
1
Proto-Oncogene Proteins c-akt (Protein Kinase B)
IBA
11/2005
Therapy/Procedure
3
Therapeutics
01/2017 - 01/2013
2
Drug Therapy (Chemotherapy)
01/2018 - 11/2012